SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.160+1.9%Nov 19 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: twt who wrote (486)11/10/1998 5:41:00 PM
From: Anthony Wong  Read Replies (1) of 2539
 
CNBC's Market Wrap had a piece on Celebrex and Vioxx by Amanda Grove. The usual positve spin about the two drugs being potential blockbusters with revenue of up to $5 billion etc. Drug analysts from A.G. Edwards and Bear Stearns were interviewed. Both Merck and Monsanto's fortunes are said to hinge on their Cox-2 inhibitor drug. Amanda Grove said that Merck will soon submit NDA to FDA. Date to note would be Dec. 1 (and don't we all know!). General positive piece of reporting.

CNN, CBS, ABC should all be picking up the ACR news.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News